Skip to main content
. 2016 Jun 14;7(29):46014–46027. doi: 10.18632/oncotarget.10014

Figure 7. Ikaros promotes SH2B3 expression via chromatin remodeling.

Figure 7

A-D. The CK2 inhibitor, TBB, increases the enrichment of Ikaros (A,C) and H3K4me3 (B,D) in B-ALL cells and patients' samples. The cells were treated with TBB 25μM for 1-2 days and qChIP was performed as described in methods section. E. TBB increases KDM5B binding at the SH2B3 promoter in patient samples.